Treatment of central sleep apnea in patients with heart failure: Now and future

doi:10.5320/wjr.v9.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9032)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

430

WORD

267

HTML

6230

Tables (1-4)

200

Sum=7127

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

762

Download

1143

Sum=1905

Jan 17, 2019 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Respirology

ISSN

2218-6255

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Respirol. Jan 17, 2019; 9(1): 1-7
Published online Jan 17, 2019. doi: 10.5320/wjr.v9.i1.1

Table 1 Short term randomized control trial investigating the effects of continuous positive airway pressure treatment on cardiac functions in heart failure patients with central sleep apnea

Author, year	Duration	n	Design	Findings
Naughton, 1995[7]	1 mo	25	no-CSA vs CPAP vs CSA-control	Urine and plasma NE↓, LVEF↑, NYHA class↓
Naughton, 1995[8]	3 mo	29	no-CSA vs CPAP vs CSA-control	LVEF↑, improve symptoms
Granton, 1996[30]	3 mo	17	CPAP vs CSA-control	MIP↑, LVEF↑, improve symptoms
Tkacova, 1997[9]	3 mo	17	CPAP vs CSA-control	LVEF↑, Mitral regurgitant fraction↓, plasma ANP↓

RCT: Randomized control trial; CPAP: Continuous positive airway pressure; HF: Heart failure; CSA: Central sleep apnea; LVEF: Left ventricular ejection fraction; NYHA: New York Heart Association; NE: Norepinephrine; MIP: Maximal inspiratory pressure; ANP: Atrial natriuretic peptide.

Citation: Murata A, Kasai T. Treatment of central sleep apnea in patients with heart failure: Now and future. World J Respirol 2019; 9(1): 1-7
URL: https://www.wjgnet.com/2218-6255/full/v9/i1/1.htm
DOI: https://dx.doi.org/10.5320/wjr.v9.i1.1